89 Results for "

3CL protease

" in MedChemExpress (MCE) Product Catalog:
Products (89)

89 Results for "3CL protease" in MCE Product Catalog:

7
7 Cited Publications
Cat. No.: HY-17430
CAS No.: 161814-49-9
Synonyms: VX-478
Target:  

HIV HIV Protease SARS-CoV

Research Areas:  

Infection Cancer

Amprenavir (VX-478) is a HIV protease inhibitor (Ki=0.6 nM) used to treat HIV infection. Amprenavir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 1.09 μM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10300
CAS No.: 865466-24-6
Purity:  95.46%
Synonyms: SCH 900518; Arlansa
Target:  

HCV HCV Protease SARS-CoV

Research Areas:  

Infection

Narlaprevir (SCH 900518) is a selective and orally bioavailable NS3 protease inhibitor with a Ki value of 6 nM and an EC90 value of 40 nM . Narlaprevir also inhibits the HCV nonstructural protein 3 serine protease . Narlaprevir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.3 μM .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-137048
CAS No.: 870153-29-0
Purity:  99.31%
Target:  

SARS-CoV HIV HCV

Research Areas:  

Infection

PF-00835231 is a CoV-2 cysteine 3C-like protease (3CL pro) inhibitor, with IC50s of 0.27 nM and 4 nM for SARS CoV-2 and SARS CoV-1 3CL pro, respectively. PF-00835231 is developed for the research of anti-SARS-CoV-2/COVID-19. PF-00835231 can inhibit cell infections and also suppress infections in animal models .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-156654
CAS No.: 2755812-39-4
Purity:  99.90%
Synonyms: PF-07817883
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

Ibuzatrelvir (PF-07817883), a second-generation, orally bioavailable, is SARS-CoV-2 main protease (M pro and 3CL pro) inhibitor with improved metabolic stability. Ibuzatrelvir has demonstrated pan-human coronavirus antiviral activity and off-target selectivity profile in vitro and in preclinical animal studies. Ibuzatrelvir is well tolerated with a safety profile similar to placebo and prevents viral infection and transmission. Ibuzatrelvir can be used to inhibit COVID-19 .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108137
CAS No.: 119670-30-3
Purity:  99.88%
Target:  

Cathepsin HSV SARS-CoV

Research Areas:  

Infection Inflammation/Immunology

Z-LVG-CHN2 is a cell-permeable and irreversible inhibitor of cysteine proteinase. Z-LVG-CHN2 is a tripeptide derivative and mimics part of the human cysteine proteinase-binding center. Z-LVG-CHN2 displays an inhibition on HSV whereas no significant effect on poliovirus replication. Z-LVG-CHN2 effectively blocks SARS-COV-2 replication (EC50=190 nM) via inhibition of SARS-COV-2 3CL pro protease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-90001R
CAS No.: 155213-67-5
Synonyms: ABT 538 (Standard); RTV (Standard)
Ritonavir (Standard) is the analytical standard of Ritonavir. This product is intended for research and analytical applications. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 1.61 μM.
loading...
    loading...
Cat. No.: HY-156651
CAS No.: 2773516-53-1
Purity:  99.71%
Synonyms: EDP-235
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

Zevotrelvir (EDP-235) is a coronavirus inhibitor that can inhibit 229E hCoV and the SARS-CoV-2 3C-like (3CL) protease (IC50 <0.1 mM). Zevotrelvir can be used in research on coronavirus infections .
loading...
    loading...
Cat. No.: HY-147020
CAS No.: 2922281-15-8
Purity:  ≥98.0%
Synonyms: NK01-63
Target:  

SARS-CoV

Research Areas:  

Infection

Coronastat is a potent inhibitor of the SARS-CoV-2 3CL protease. The SARS-CoV-2 3CL protease is a critical agent target for small molecule COVID-19, given its likely agentgability and essentiality in the viral maturation and replication cycle .
loading...
    loading...
Cat. No.: HY-149767
CAS No.: 2882934-64-5
Target:  

SARS-CoV

Research Areas:  

Infection

CMX990 is a SARS-CoV-2 3CL protease inhibitor. The EC90s for inhibiting SARS-CoV-2 were 9.6 nM and 101 nM in human bronchial epithelial cells (HBECs) and HeLa-ACE2 cells, respectively. CMX990 has good ADME and pharmacokinetic properties .
loading...
    loading...
Cat. No.: HY-152009
CAS No.: 1164478-67-4
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 3CLpro-IN-7 is a reversible covalent SARS-CoV-2 3CL protease inhibitor with an IC50 value of 1.4 µM .
loading...
    loading...
Cat. No.: HY-152005
CAS No.: 302821-53-0
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 3CLpro-IN-6 is a reversible covalent inhibitor of SARS-CoV-2 3CL protease. SARS-CoV-2 3CLpro-IN-6 has potent inhibitory activity for SARS-CoV-2 3CL pro with an IC50 value of 4.9 μM. SARS-CoV-2 3CLpro-IN-6 can be used for the research of coronavirus disease 2019 (COVID-19) .
loading...
    loading...
Cat. No.: HY-149264
CAS No.: 622794-09-6
Purity:  ≥99.0%
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 3CLpro-IN-13 is a potent SARS-CoV-2 3CL protease inhibitor with an IC50 value of 21 nM. SARS-CoV-2 3CLpro-IN-13 shows anti-coronavirus activity .
loading...
    loading...
Cat. No.: HY-169847
CAS No.: 247188-27-8
Target:  

SARS-CoV Dengue Virus

Research Areas:  

Infection

ZK-806450 is a compound with antiviral activity. ZK-806450 has a high binding potential to the allosteric binding site of the SARS-CoV-2 3CL protease. ZK-806450 can also specifically and stably bind to the GAG site of the dengue virus envelope protein .
loading...
    loading...
Cat. No.: HY-138687R
CAS No.: 2628280-40-8
Synonyms: PF-07321332 (Standard)
Nirmatrelvir (Standard) is the analytical standard of Nirmatrelvir. This product is intended for research and analytical applications. Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV 3C-like protease (3CL PRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research .
loading...
    loading...
Cat. No.: HY-144062
CAS No.: 2735704-33-1
Target:  

SARS-CoV

Research Areas:  

Infection

INSCoV-614(1B) is a potent inhibitor of M pro (3CL pro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-614(1B) has the potential for the research of SARS-CoV-2 infection (extracted from patent WO2021219089A1) .
loading...
    loading...
Cat. No.: HY-N8471
CAS No.: 147821-57-6
Niazinin is a thiocarbamate glycoside with antileishmanial activities, with an IC50 value of 5.25 μM. Niazinin also shows a binding affinity with the target protein 3CL protease. Niazinin has promising leishmanicidal, anti-inflammatory and anti-pyretic activity .
loading...
    loading...
Cat. No.: HY-B2074
CAS No.: 24701-51-7
Target:  

SARS-CoV

Research Areas:  

Neurological Disease

Demexiptiline is a tricyclic antidepressant. Demexiptiline is a norepinephrine reuptake inhibitor. Demexiptiline has a binding affinity with SARS-CoV-2 3CL protease of 8.14 kcal/mol. Demexiptiline can also be studied in research on melancholic states .
loading...
    loading...
Cat. No.: HY-14909R
CAS No.: 218600-44-3
Synonyms: CDDO (Standard); RTA 401 (Standard)
Bardoxolone (Standard) is the analytical standard of Bardoxolone (HY-14909). This product is intended for research and analytical applications. Bardoxolone is an orally active activator of nuclear regulatory factor (NRf-2) and an inhibitor of SARS-CoV-2 3CL protease. Bardoxolone inhibits SARS-CoV-2 3CL protease with an EC50 value of 0.43 μM in vero cells. Bardoxolone also inhibits necroptosis in HT-29 cells with an EC50 value of 1.30 μM by blocking necrosome formation through inhibiting phosphorylation of RIPK1 and RIPK3. Bardoxolone can be used in research on COVID-19, TNF-induced systemic inflammatory response syndrome (SIRS), and cerebral ischemia-reperfusion injury .
loading...
    loading...
Cat. No.: HY-10237R
CAS No.: 394730-60-0
Synonyms: EBP 520 (Standard); SCH 503034 (Standard)
Research Areas:  

Infection

Boceprevir (Standard) is the analytical standard of Boceprevir. This product is intended for research and analytical applications. Boceprevir (EBP 520) is a potent, highly selective, orally bioavailable HCV NS3 protease inhibitor with a Ki of 14 nM in both enzyme assay and an EC90 of 350 nM in cell-based replicon assay . Boceprevir inhibits SARS-CoV-2 3CL pro activity .
loading...
    loading...
Cat. No.: HY-15298C
CAS No.: 1425038-27-2
Synonyms: MK-5172 sodium salt
Target:  

HCV HCV Protease SARS-CoV

Research Areas:  

Infection

Grazoprevir sodium salt (MK-5172 sodium salt) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively . Grazoprevir sodium salt inhibits SARS-CoV-2 3CL pro activity .
loading...
    loading...